JNK-IN-19
JNK-IN-19 (Compound Q8) is a c-Jun N-terminal kinase inhibitor that is used for treating and/or preventing an injury before, during, or after a surgical procedure[1].
Product Specifications
CAS Number
3059122-56-1
UNSPSC
12352005
Target
JNK
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/jnk-in-19.html
Smiles
O=P(OCN1C2=CN=C(N=C2N(/C1=N/C3=C(C=C(C=C3F)F)F)[C@H]4CCOC4)N[C@H]5CC[C@@H](CC5)O)(O[Na])O[Na]
Molecular Formula
C22H24F3N6Na2O6P
Molecular Weight
602.41
References & Citations
[1]SATOH Yoshi, et al. PREVENTION/TREATMENT OF ISCHEMIC REPERFUSION INJURY. WO2024211291. 2024 October 10.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-0255R-Cy7 100 µL
Estrogen receptor beta Antibody, Cy7 Conjugated
Sign In for Pricing
View Details ARP60607_P050-Biotin 100 µL
SPSB2 Antibody - N-terminal region : Biotin (ARP60607_P050-Biotin)
Sign In for Pricing
View Details